Publication:
Integrated miRNA and mRNA expression profiling identifies novel targets and pathological mechanisms in autoimmune thyroid diseases

dc.contributor.authorMartínez-Hernández, Rebeca
dc.contributor.authorSerrano-Somavilla, Ana
dc.contributor.authorRamos-Leví, Ana
dc.contributor.authorSampedro-Nuñez, Miguel
dc.contributor.authorLens-Pardo, Alberto
dc.contributor.authorMuñoz De Nova, José Luis
dc.contributor.authorTriviño, Juan Carlos
dc.contributor.authorGonzález, María Ujue
dc.contributor.authorTorné, Lorena
dc.contributor.authorCasares-Arias, Javier
dc.contributor.authorMartin-Cofreces, Noa B.
dc.contributor.authorSanchez-Madrid, Francisco
dc.contributor.authorMarazuela, Mónica
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderComunidad de Madrid (España)
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
dc.contributor.funderMinisterio de Economía, Industria y Competitividad (España)
dc.date.accessioned2020-01-29T08:21:00Z
dc.date.available2020-01-29T08:21:00Z
dc.date.issued2019-12
dc.description.abstractBACKGROUND: The mechanisms underlying autoimmune thyroid disease (AITD) remain elusive. Identification of such mechanisms would reveal novel and/or better therapeutic targets. Here, we use integrated analysis of miRNAs and mRNAs expression profiling to identify potential therapeutic targets involved in the mechanisms underlying AITD. METHODS: miRNA and mRNA from twenty fresh-frozen thyroid tissues (15 from AITD patients and 5 from healthy controls) were subjected to next-generation sequencing. An anti-correlated method revealed potential pathways and disease targets, including proteins involved in the formation of primary cilia. Thus, we examined the distribution and length of primary cilia in thyroid tissues from AITD and controls using immunofluorescence and scanning electron microscopy, and parsed cilia formation in thyroid cell lines in response to inflammatory stimuli in the presence of miRNA mimics. FINDINGS: We found that the expression of miR-21-5p, miR-146b-3p, miR-5571-3p and miR-6503-3p was anti-correlated with Enolase 4 (ENO4), in-turned planar cell polarity protein (INTU), kinesin family member 27 (KIF27), parkin co-regulated (PACRG) and serine/threonine kinase 36 (STK36) genes. Functional classification of these miRNA/mRNAs revealed that their differential expression was associated with cilia organization. We demonstrated that the number and length of primary cilia in thyroid tissues was significantly lower in AITD than in control (frequency of follicular ciliated cells in controls = 67.54% vs a mean of 22.74% and 21.61% in HT and GD respectively p = 0.0001, by one-way ANOVA test). In addition, pro-inflammatory cytokines (IFNγ and TNFα) and specific miRNA mimics for the newly identified target genes affected cilia appearance in thyroid cell lines. INTERPRETATION: Integrated miRNA/gene expression analysis has identified abnormal ciliogenesis as a novel susceptibility pathway that is involved in the pathogenesis of AITD. These results reflect that ciliogenesis plays a relevant role in AITD, and opens research pathways to design therapeutic targets in AITD. FUNDING: Instituto de Salud Carlos III, Comunidad de Madrid, Grupo Español de Tumores Neuroendocrinos y Endocrinos, Ministerio de Economía y Empresa and FEDER.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis work was supported by the following grants: Proyectos de Investigacion en Salud (FIS) PIE13-0041 and PI16-02091 (funded by Institute de Salud Carlos III), TIRONET2-CM, B2017/BMD-3724 (funded by Comunidad de Madrid), GETNE G1707 (funded by Grupo Espanol de Tumores Neuroendocrinos y Endocrinos) and cofinanced by FEDER funds to MM. We also acknowledge the service from the MiNa Laboratory at IMN, and funding from CM (project S2018/NMT-4291 TEC2SPACE), MINECO (project CSIC13-4E-1794) and EU (FEDER, FSE) to M.U.G.es_ES
dc.format.page329-342es_ES
dc.format.volume50es_ES
dc.identifier.citationEBioMedicine. 2019; 50:329-342es_ES
dc.identifier.doi10.1016/j.ebiom.2019.10.061es_ES
dc.identifier.e-issn2352-3964es_ES
dc.identifier.issn2352-3964es_ES
dc.identifier.journalEBioMedicinees_ES
dc.identifier.pubmedID31735554es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/8927
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PIE13-0041es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI16-02091es_ES
dc.relation.publisherversionhttps://doi.org/10.1016/j.ebiom.2019.10.061es_ES
dc.repisalud.institucionCNICes_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Comunicación Intercelular en la Respuesta Inflamatoriaes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAutoimmune thyroid diseasees_ES
dc.subjectCiliaes_ES
dc.subjectGraves’ diseasees_ES
dc.subjectHashimoto's thyroiditises_ES
dc.subjectNext generation sequencinges_ES
dc.subjectmRNAes_ES
dc.subjectmicroRNAses_ES
dc.titleIntegrated miRNA and mRNA expression profiling identifies novel targets and pathological mechanisms in autoimmune thyroid diseaseses_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication430026b8-0402-4333-9c31-7ab281b93824
relation.isAuthorOfPublication51eb6cbc-309f-4845-987e-5b2cea239c59
relation.isAuthorOfPublication.latestForDiscovery430026b8-0402-4333-9c31-7ab281b93824

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
IntegratedmiRNAmRNAexpression_2019.pdf
Size:
6.1 MB
Format:
Adobe Portable Document Format
Description:
Loading...
Thumbnail Image
Name:
IntegratedmiRNAmRNAexpression_2019-mmc1.pdf
Size:
935.54 KB
Format:
Adobe Portable Document Format